BMJ Support Palliat Care:电针治疗可有效改善老年女性的压力性尿失禁

2022-06-02 sunshine MedSci原创

EA可能是治疗老年和非老年妇女SUI或压力为主的MUI的有效和安全的替代疗法。年龄可能不会影响电针的治疗效果。

尿失禁,即非自愿性的尿液流失,是女性常见的抱怨常见于女性。压力性尿失禁(SUI)或压力为主的混合性尿失禁(MUI)的特点是在体力消耗、打喷嚏或咳嗽时尿液不自主地从尿道口漏出。近日,发表于BMJ Support Palliat Care的一项随机对照研究比较了电针(EA)对老年和非老年妇女SUI或MUI的疗效。

本研究是对两项随机对照试验的二次分析,纳入了252名SUI妇女和132名以压力为主的MUI妇女,均接受了相同的EA方案治疗。老年妇女被定义为年龄大于60岁者。主要研究结果是,从基线到第6周,平均72小时尿失禁发作频率(IEF)下降≥50%的患者比例。总体而言,在SUI和MUI试验中共招募了1004名妇女。在EA组中,基线时以急迫性为主或平衡型MUI的患者被排除在本次研究之外,因此最终的样本量为384人。

结果,在384名接受EA治疗的SUI或压力为主的MUI患者中,371人完成了研究。分析结果显示,经过6周的治疗,72小时平均IEF比基线下降≥50%的女性比例,老年组为57.3%(51/89),非老年组为60.70%(173/285);组间差异不大(3.11%,95%CI-9.83%至16.05%;P=0.637)。在第4、16和28周观察到类似的结果。两组患者的72小时IEF、漏尿量(通过1小时尿垫测试评估)和国际失禁症调查问卷-短表得分都比基线有所下降,组间差异不明显。研究期间没有观察到明显的EA相关不良事件。

综上所述,该研究结果表明,EA可能是治疗老年和非老年妇女SUI或压力为主的MUI的有效和安全的替代疗法。年龄可能不会影响电针的治疗效果。

原始出处:

Biyun Sun, et al., Electroacupuncture for stress-related urinary incontinence in elderly women: data analysis from two randomised controlled studies. BMJ Support Palliat Care. 2022 May;12(e1):e164-e170. doi: 10.1136/bmjspcare-2019-002034.  

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1849417, encodeId=aa9d184941ee8, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Feb 14 04:32:13 CST 2023, time=2023-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677362, encodeId=e1f216e7362b8, content=<a href='/topic/show?id=943ee01828f' target=_blank style='color:#2F92EE;'>#电针#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70182, encryptionId=943ee01828f, topicName=电针)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86427488550, createdName=yulin2015, createdTime=Sun Jul 17 12:32:13 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795213, encodeId=16e81e952139b, content=<a href='/topic/show?id=5cd1169138f' target=_blank style='color:#2F92EE;'>#support#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16913, encryptionId=5cd1169138f, topicName=support)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Sun Dec 04 09:32:13 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281695, encodeId=d9e9128169559, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329618, encodeId=e0bd1329618de, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
    2023-02-14 gaoxiaoe
  2. [GetPortalCommentsPageByObjectIdResponse(id=1849417, encodeId=aa9d184941ee8, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Feb 14 04:32:13 CST 2023, time=2023-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677362, encodeId=e1f216e7362b8, content=<a href='/topic/show?id=943ee01828f' target=_blank style='color:#2F92EE;'>#电针#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70182, encryptionId=943ee01828f, topicName=电针)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86427488550, createdName=yulin2015, createdTime=Sun Jul 17 12:32:13 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795213, encodeId=16e81e952139b, content=<a href='/topic/show?id=5cd1169138f' target=_blank style='color:#2F92EE;'>#support#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16913, encryptionId=5cd1169138f, topicName=support)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Sun Dec 04 09:32:13 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281695, encodeId=d9e9128169559, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329618, encodeId=e0bd1329618de, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
    2022-07-17 yulin2015
  3. [GetPortalCommentsPageByObjectIdResponse(id=1849417, encodeId=aa9d184941ee8, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Feb 14 04:32:13 CST 2023, time=2023-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677362, encodeId=e1f216e7362b8, content=<a href='/topic/show?id=943ee01828f' target=_blank style='color:#2F92EE;'>#电针#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70182, encryptionId=943ee01828f, topicName=电针)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86427488550, createdName=yulin2015, createdTime=Sun Jul 17 12:32:13 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795213, encodeId=16e81e952139b, content=<a href='/topic/show?id=5cd1169138f' target=_blank style='color:#2F92EE;'>#support#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16913, encryptionId=5cd1169138f, topicName=support)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Sun Dec 04 09:32:13 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281695, encodeId=d9e9128169559, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329618, encodeId=e0bd1329618de, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
    2022-12-04 wetgdt
  4. [GetPortalCommentsPageByObjectIdResponse(id=1849417, encodeId=aa9d184941ee8, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Feb 14 04:32:13 CST 2023, time=2023-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677362, encodeId=e1f216e7362b8, content=<a href='/topic/show?id=943ee01828f' target=_blank style='color:#2F92EE;'>#电针#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70182, encryptionId=943ee01828f, topicName=电针)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86427488550, createdName=yulin2015, createdTime=Sun Jul 17 12:32:13 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795213, encodeId=16e81e952139b, content=<a href='/topic/show?id=5cd1169138f' target=_blank style='color:#2F92EE;'>#support#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16913, encryptionId=5cd1169138f, topicName=support)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Sun Dec 04 09:32:13 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281695, encodeId=d9e9128169559, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329618, encodeId=e0bd1329618de, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1849417, encodeId=aa9d184941ee8, content=<a href='/topic/show?id=2977356edc' target=_blank style='color:#2F92EE;'>#BMJ#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=60, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=3567, encryptionId=2977356edc, topicName=BMJ)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=148754, createdName=gaoxiaoe, createdTime=Tue Feb 14 04:32:13 CST 2023, time=2023-02-14, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1677362, encodeId=e1f216e7362b8, content=<a href='/topic/show?id=943ee01828f' target=_blank style='color:#2F92EE;'>#电针#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=32, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=70182, encryptionId=943ee01828f, topicName=电针)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=a86427488550, createdName=yulin2015, createdTime=Sun Jul 17 12:32:13 CST 2022, time=2022-07-17, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1795213, encodeId=16e81e952139b, content=<a href='/topic/show?id=5cd1169138f' target=_blank style='color:#2F92EE;'>#support#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=38, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=16913, encryptionId=5cd1169138f, topicName=support)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=1e34303, createdName=wetgdt, createdTime=Sun Dec 04 09:32:13 CST 2022, time=2022-12-04, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1281695, encodeId=d9e9128169559, content=<a href='/topic/show?id=0c3c4e407ec' target=_blank style='color:#2F92EE;'>#尿失禁#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=47407, encryptionId=0c3c4e407ec, topicName=尿失禁)], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=872f168, createdName=gracezdd, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1329618, encodeId=e0bd1329618de, content=<a href='/topic/show?id=bb96232801' target=_blank style='color:#2F92EE;'>#ALL#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=2328, encryptionId=bb96232801, topicName=ALL)], attachment=null, authenticateStatus=null, createdAvatar=http://thirdqq.qlogo.cn/qqapp/1103841572/C2EFD5CFB07FE291138AD4FD0C98E3DE/100, createdBy=e3d52500031, createdName=膀胱癌, createdTime=Tue May 31 06:32:13 CST 2022, time=2022-05-31, status=1, ipAttribution=)]
    2022-05-31 膀胱癌

相关资讯

Eur Urol Focus:非转移性前列腺癌根治术后尿失禁的患者和肿瘤相关预后因素分析

非转移性前列腺癌(PCa)患者最常见的一线治疗方法之一是根治性前列腺切除术(RP)。尿失禁(UI)是功能性并发症之一,且术后12个月时的UI率为4%至31%。已报道的术后UI率的差异可能与患者和外科医

J Urol:根治性前列腺切除术后新发储尿功能障碍是否常见?

评估了男性新发储尿功能障碍的流行率、自然史和风险因素。

BJU Int:根治性前列腺切除术后,哪些患者需要进行尿失禁手术干预?

调查了前列腺根治术后患者报告的尿失禁和困扰评分是否会导致随后的尿失禁手术干预。

EU :腹腔镜 VS 机器人 哪种方式进行根治性前列腺切除术更好?

根治性前列腺切除术(RP)后尿失禁深深地影响患者生活质量。机器人辅助根治性前列腺切除术(RARP)和腹腔镜RP (LRP)是常用的手术方式,研究显示它们对肿瘤治疗效果无差异,而前者对控尿更好。

Radiology:这一前列腺MRI测量值,可实现对前列腺切除术后尿失禁的无创预测!

根治性前列腺切除术(RP)后的尿失禁是决定患者生活质量的一个重要因素。在一项荟萃分析中,RP术后1年的尿失禁发生率为4%至31%。

Eur Urol Focus:人工尿道括约肌治疗术后应激性尿失禁的效果如何?

比较了PPI患者植入AUS后的尿失禁结果与BPO手术后植入AUS的尿失禁结果。